PATRICIA BARRON: Open Payments
NPI 1740246503 · MORRISTOWN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$470 in 12 payments from 5 companies in 2025. Trend: 2023 $913 · 2024 $901 · 2025 $470
Food & beverage: $470
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 7 | $276 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $105 |
| Teva Pharmaceuticals USA, Inc. | 1 | $39 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $36 |
| ABBVIE INC. | 1 | $14 |
Products named: REXULTI, ABILIFY MAINTENA, CAPLYTA, UZEDY, TRINTELLIX, VRAYLAR.
Industry payments across NJ — which companies pay providers there.
